Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 10,021	$ 13,517
Trade accounts receivable, less allowance for doubtful accounts of $143 and $144, respectively	17,403	11,639	[1]
Prepaid expenses	2,608	2,038
Income taxes receivable	580	69
Insurance receivable	2,771
Other current assets	1,556	1,894
Total current assets	34,939	29,157
Net property and equipment	12,655	13,530
Intangible assets, net	1,635	1,728
Goodwill	57,746	57,935
Deferred contract costs, net	4,896	4,204
Operating ROU assets	1,460	1,628	[2]
Other	2,524	2,503
Total assets	115,855	110,685
Current liabilities:
Current portion of notes payable	4,631	4,378
Accounts payable	655	1,279
Accrued wages, bonus and profit sharing	4,913	6,086
Accrued expenses	4,292	3,408
Income taxes payable		366
Dividends payable	5,278	5,239
Deferred revenue	19,111	16,354	[1]
Other current liabilities	999	1,045
Total current liabilities	39,879	38,155
Notes payable, net of current portion and unamortized debt issuance costs	28,593	29,795
Deferred income taxes	7,704	7,399
Other long term liabilities	2,382	2,444
Total liabilities	78,558	77,793
Shareholders’ equity:
Preferred stock, $0.01 par value, authorized 2,000,000 shares, none issued	0	0
Common stock, $0.001 par value; authorized 60,000,000 shares, issued 30,412,055 in 2020 and 30,151,574 in 2019, outstanding 25,132,001 in 2020 and 24,947,500 in 2019	30	30
Additional paid-in capital	165,631	162,154
Retained earnings (accumulated deficit)	(86,880)	(93,357)
Accumulated other comprehensive loss, foreign currency translation adjustment	(3,333)	(2,209)
Treasury stock, at cost; 5,280,054 Common shares in 2020 and 5,204,074 shares in 2019	(38,151)	(33,726)
Total shareholders’ equity	37,297	32,892
Total liabilities and shareholders’ equity	$ 115,855	$ 110,685

[1] Represents the December 31, 2017 balance adjusted for the ASC 606 transition adjustments.

[2] Represents the December 31, 2018 balance recorded at implementation of Topic 842